Abstract:Precision medicine in oncology aims at obtaining data from heterogeneous sources to have a precise estimation of a given patient's state and prognosis. With the purpose of advancing to personalized medicine framework, accurate diagnoses allow prescription of more effective treatments adapted to the specificities of each individual case. In the last years, next-generation sequencing has impelled cancer research by providing physicians with an overwhelming amount of gene-expression data from RNA-seq high-throughput platforms. In this scenario, data mining and machine learning techniques have widely contribute to gene-expression data analysis by supplying computational models to supporting decision-making on real-world data. Nevertheless, existing public gene-expression databases are characterized by the unfavorable imbalance between the huge number of genes (in the order of tenths of thousands) and the small number of samples (in the order of a few hundreds) available. Despite diverse feature selection and extraction strategies have been traditionally applied to surpass derived over-fitting issues, the efficacy of standard machine learning pipelines is far from being satisfactory for the prediction of relevant clinical outcomes like follow-up end-points or patient's survival. Using the public Pan-Cancer dataset, in this study we pre-train convolutional neural network architectures for survival prediction on a subset composed of thousands of gene-expression samples from thirty-one tumor types. The resulting architectures are subsequently fine-tuned to predict lung cancer progression-free interval. The application of convolutional networks to gene-expression data has many limitations, derived from the unstructured nature of these data. In this work we propose a methodology to rearrange RNA-seq data by transforming RNA-seq samples into gene-expression images, from which convolutional networks can extract high-level features. As an additional objective, we investigate whether leveraging the information extracted from other tumor-type samples contributes to the extraction of high-level features that improve lung cancer progression prediction, compared to other machine learning approaches.

Assessment of deep learning and transfer learning for cancer prediction based on gene expression data

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Machine Learning Methods for Cancer Classification Using Gene Expression Data: A Review

DeepCancer: Detecting Cancer through Gene Expressions via Deep Generative Learning

Gene Expression-Assisted Cancer Prediction Techniques

Deep learning techniques for cancer classification using microarray gene expression data

Applying the Deep Learning Techniques to Solve Classification Tasks Using Gene Expression Data

Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations

Deep learning assisted cancer disease prediction from gene expression data using WT-GAN

The Application of Deep Learning in Cancer Prognosis Prediction

Deep learning - cancer genetics and application of deep learning to cancer oncology

Deep Learning for Cancer Type Classification and Driver Gene Identification

Enhancing Breast Cancer Prediction through Deep Learning and Comparative Analysis of Gene Expression and DNA Methylation Data using Convolutional Neural Networks

DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes

Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review

Deep Learning for identifying radiogenomic associations in breast cancer

Transfer learning with convolutional neural networks for cancer survival prediction using gene-expression data

Predicting Breast Cancer Gene Expression Signature by Applying Deep Convolutional Neural Networks From Unannotated Pathological Images

A Novel Deep Learning Method to Predict Lung Cancer Long-Term Survival With Biological Knowledge Incorporated Gene Expression Images and Clinical Data

Deep learning in breast cancer risk assessment: evaluation of convolutional neural networks on a clinical dataset of full-field digital mammograms